ADC Therapeutics SA
Posted on: January 18, 2022
By: Kim Berlowitz
With: Comments Off on ADC Therapeutics SA
MTS served as exclusive financial advisor to ADC Therapeutics on its out-licensing of ZYNLONTA in Japan to Mitsubishi Tanabe Pharma